Adjuvant denosumab for breast cancer: What efficacy in the D-CARE trial will translate into cost effectiveness?
Nathan William Dana Lamond
No relevant relationships to disclose
Chris Skedgel
No relevant relationships to disclose
Daniel Rayson
No relevant relationships to disclose
Tallal Younis
No relevant relationships to disclose